Daniel O'Day sells shares at Gilead Sciences (NASDAQ: GILD)

NodeGuardian · 2026-03-27T21:13:34+00:00

Daniel O'Day of Gilead Sciences filed Form 144 with the SEC for proposed sales of Common shares, detailing dispositions of 115,640 shares totaling $17.3 million. This filing is a standard regulatory disclosure and does not indicate finalized sales.

NodeGuardian

2026-03-27 21:13:34

Abstract generation in progress

Daniel O’Day, a reporting person for Gilead Sciences (NASDAQ: GILD), filed a Form 144 notifying the SEC of proposed sales of Common shares. The filing lists examples of dispositions, including sales of 115,640 shares for $17,346,000 on February 5, 2026, and $15,611,400 on January 23, 2026. This Form 144 is a routine regulatory disclosure and does not confirm completed sales, which would be shown in subsequent SEC filings.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.